ADHD news

All ADHD news

March 24

ADHD Mar 24 Collegium Expands ADHD Portfolio with $650M Acquisition of AZSTARYS Collegium Pharmaceutical has acquired AZSTARYS from Corium Therapeutics, expanding their CNS footprint and broadening market supply options for ADHD treatments. ADHD Mar 24 New Jersey Tightens Access to ADHD Medications Like Adderall and Ritalin New Jersey is changing how ADHD medications are prescribed to combat misuse. ADHD Mar 24 New Developments in ADHD Research and Treatment Recent advancements in ADHD research have led to a better understanding of the condition and its treatment options.

March 23

ADHD Mar 23 New Study Reveals Breakthrough in Understanding ADHD Reaction Times A new study from UCLA is challenging the traditional view of ADHD reaction time variability, offering new hope for treatment and support.

March 17

ADHD Mar 17 ADHD Brain Activity Mirrors Sleep Patterns, Affecting Attention ADHD brain activity shows sleep-like patterns, impacting attention and performance.

March 14

ADHD Mar 14 Building Social Skills Protects Young Adults From Alcohol Risks If you've watched a young adult struggle socially and felt helpless, research confirms there's something powerful you can do: building social skills creates protection against alcohol use risks. Here's what… ADHD Mar 14 UK Experts: No Evidence of Overdiagnosis as Focus Gaps Persist New research from UK experts finds no evidence of ADHD overdiagnosis, with rates actually below international estimates. Here's what this means for families navigating attention and focus concerns. ADHD Mar 14 New Research Reveals What Really Drives Anxiety in Teens Building Focus Skills A groundbreaking study of over 5,000 adolescents reveals that low self-esteem and parental mental health—not attention challenges themselves—are the strongest predictors of anxiety and depression in teens. For girls, peer… ADHD Mar 14 Penn State Research Reveals Treatment Gap for Young People Building Focus Skills Amid Substance Challenges New research reveals a troubling paradox: while CNS stimulants reduce mortality by 30% for youth navigating attention and substance challenges, prescriptions drop sharply after substance use diagnoses. Here's what parents… ADHD Mar 14 After COVID, More Adults Than Ever Are Being Prescribed Stimulants—But There’s Another Path The number of adults prescribed stimulants in Ontario more than doubled after the pandemic began. By mid-2024, 1 in 50 adults aged 18-34 had received these medications. But here's what…